Product Information
LEVOCARNITINE 1 G/10 ML SOLN is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1450 per ML under NDC 70954013910. Its NADAC has been published 349 times since Jan 29, 2020.
FDA first approved this application on Aug 14, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 g/10mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954013910
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOCARNITINEApproval Type
Generic (ANDA)
FDA Application
ANDA211676FDA Approved
8/14/2019
TE Code
AA
On Market Since
8/14/2019
Pharmacological Classes
Price Statistics
The NADAC for LEVOCARNITINE 1 G/10 ML SOLN has been published 349 times since Jan 29, 2020, and over the history we have for it it has declined 48.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1450 per ML |
|---|---|
| All-time high | $0.2879 (Mar 11, 2020) |
| All-time low | $0.1106 (Jul 17, 2024) |
| 52-week high | $0.1502 |
| 52-week low | $0.1329 |
| Median price | $0.1915 |
| Average price | $0.1979 |
| Largest weekly change | +40.1% (Aug 21, 2024) |
| Weeks tracked | 349 |
| Tracking since | Jan 29, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levocarnitine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carnitine Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOCARNITINE 1 G/10 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCARNITINE 1 G/10 ML SOLN, manufactured by ANI Pharmaceuticals, Inc., is $0.1450 per ML (NDC 70954013910), effective Sep 30, 2026.
How has the price of LEVOCARNITINE 1 G/10 ML SOLN changed over time?
Over the history we have for it, the NADAC for LEVOCARNITINE 1 G/10 ML SOLN has declined 48.9%. It has been tracked across 349 weekly CMS publications since Jan 29, 2020.
What are the highest and lowest recorded NADAC prices for LEVOCARNITINE 1 G/10 ML SOLN?
Since Jan 29, 2020, the NADAC for LEVOCARNITINE 1 G/10 ML SOLN has ranged from a low of $0.1106 (Jul 17, 2024) to a high of $0.2879 (Mar 11, 2020), with a median of $0.1915 per ML.
Are there cheaper alternatives to LEVOCARNITINE 1 G/10 ML SOLN?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVOCARNITINE 1 G/10 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVOCARNITINE 1 G/10 ML SOLN?
LEVOCARNITINE 1 G/10 ML SOLN (NDC 70954013910) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.